Format

Send to

Choose Destination
Diagn Microbiol Infect Dis. 2018 Nov;92(3):206-209. doi: 10.1016/j.diagmicrobio.2017.12.011. Epub 2017 Dec 21.

Survey of diagnostic testing for respiratory syncytial virus (RSV) in adults: Infectious disease physician practices and implications for burden estimates.

Author information

1
IHRC, Inc., contracting agent to the Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: xxk4@cdc.gov.
2
University of Iowa Carver College of Medicine, Iowa City, IA.
3
Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
4
Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Atlanta, GA.
5
Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: iyn2@cdc.gov.

Abstract

Respiratory syncytial virus (RSV) often causes respiratory illness in adults. Over 40 RSV vaccine and monoclonal antibody products are currently in preclinical development or clinical trials. Because RSV diagnostic practices may impact disease burden estimates, we investigated infectious disease physicians' RSV diagnostic practices among their adult patients.

KEYWORDS:

Diagnostic testing; Polymerase chain reaction (PCR); Rapid antigen detection test (RADT); Respiratory syncytial virus (RSV); Respiratory viral panel (RVP)

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center